Pharmaceutical composition for treating chronic nephritis damp heat syndrome and preparation method for pharmaceutical composition

Abstract

The invention discloses a pharmaceutical composition for treating chronic nephritis damp heat syndrome. The pharmaceutical composition is prepared from astragalus membranaceus, eucommia ulmoides, prepared fleece flower roots, cherokee rose fruits, pyrrosia lingua, hedyotis diffusa, radix ranunculi ternati, prepared stiff silkworms and fried angelica sinensis and is suitable for the chronic nephritis damp heat syndrome and primary mesangial proliferative glomerulonephritis. The symptoms are as follows: lumbar acerbity sluggish, short breath, laziness to speak, lusterless complexion, feverishness in palms and soles, dizziness and tinnitus, enuresis nocturna, yellowish fur, bitter taste in mouth, sticky and greasy fur, dry mouth, less drinking, scanty dark urine, difficulty and pain in micturition, recurrent upper respiratory or gastrointestinal tract infection and face and limb edema. The pharmaceutical composition has the effects of benefiting qi, tonifying spleen, clearing heat and promoting diuresis, is not obvious in drug flavor, good in medicinal effect, safe and effective, and can be prepared into various oral preparations.

Description

technical field [0001] The invention relates to a medicinal composition derived from traditional Chinese medicine for treating damp-heat syndrome of chronic nephritis and a preparation method thereof. Background technique [0002] Following the concept of tertiary prevention of chronic kidney disease (CKD) proposed by the international nephrology community, the K / DOQI organization in the United States re-established the clinical practice guidelines for CKD in 1999, pointing out that proteinuria is an important risk factor that accelerates the progression of CKD. one. [0003] Chronic primary glomerular disease is the most common cause of CKD, clinically including chronic glomerulonephritis, occult glomerulonephritis or nephrotic syndrome, pathological manifestations include mild glomerular lesions, focal glomerular Nephritis, focal segmental glomerulosclerosis, mesangial proliferative glomerulonephritis, membranous nephropathy, mesangial capillary nephritis, IgA nephropathy...

AI Technical Summary

Problems solved by technology

In terms of treatment, Western medicine has formed a relatively complete treatment system. The clinical efficacy of hormones, immunosuppressants, RAS blockers, and anticoagulants have been verified in the industry for a long time. It is believed that they can effectively control proteinuria, Protect renal function, but these treatments are mainly aimed at patients with clinical manifestations of nephrotic syndrome or nephrotic range proteinuria, and are not completely suitable for non-nephrotic range proteinuria, and the course of western medicine treatment is long, easy to rebound after drug withdrawal, side effects also more